Digital Health, Artificial Intelligence & Internet of Everything
We empower clients to capitalize on Digital Health, AI, and IoE - accelerating success in these emerging fields. Leveraging robust research capabilities, we deliver strategic insights enabling partners to build winning solutions and gain a competitive edge.
We empower Pharma, Biotech, Healthcare and HealthTech/MedTech companies to capitalize on Digital Health, AI and IoE, accelerating their competitive advantage.
As trusted partners, we provide strategic support spanning areas such as:
- Collaborative projects with BioPharma innovation units and patient solution teams
- Intensive patient-centricity research, placing the end-user at the heart of every solution
- Trend analysis in AI, wearable tech, digital therapeutics, and comprehensive digital health solutions
- Creation and support in AI-powered tool development for enhanced data intelligence
- Joint strategy formulation for competitive digital health and AI initiatives
- Pioneering research on the transformative impact of AI/IoE on healthcare, from “smart” homes to “smart” appliances
With robust research and consulting, we deliver evidence-based solutions, enabling clients to implement winning digital strategies.
Ready to accelerate innovation?
Let’s build winning tech strategies together. Contact us at info@lqventures.com.
October 27, 2025
Oncology Today — October 27, 2025
October 27, 2025
AI in Healthcare and Digital Health Today—October 27, 2025
October 27, 2025
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences
October 26, 2025
Lucid Diligence Brief: ENA Respiratory Series B for Intranasal INNA-051
October 25, 2025
Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies
October 24, 2025
Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A
October 24, 2025
Public Health Today—October 24, 2025
October 24, 2025
Public Health Video Recap—October 24, 2025
October 24, 2025
Respiratory Today—October 24, 2025
October 24, 2025
Vaccines Today—October 24, 2025
October 24, 2025
Lucid Diligence Brief: Electra Therapeutics $183M Series C
October 23, 2025